Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation
Journal of Allergy and Clinical Immunology · 2026-07 · 158 (1) · 164-181
DOI: 10.1016/j.jaci.2026.02.036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-07. Verfasst von Maria Jesus Valle-Pastor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior d…. Hauptthemen laut MEDLINE: Dasatinib, Interleukin-23, src-Family Kinases, Protein Kinase Inhibitors. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Centro de Biologia Molecular Severo Ochoa, Centro Nacional de Biotecnología.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
- Physiological and Pathological Processes Program, Metabolic and Signaling Networks in Disease Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain; Department o…
- Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain. Electronic address: mari…
Förderung
- Centro de Biologia Molecular Severo Ochoa
- Centro Nacional de Biotecnología
Zitieren
APA
Valle-Pastor, M. J., Cayuela, I., Yebra, J. S., Senach-Rasilla, L., Pastor-Fernández, G., Oliva, A., Traba, J., & Navarro, M. N. (2026). Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation. Journal of Allergy and Clinical Immunology, 158(1), 164-181. https://doi.org/10.1016/j.jaci.2026.02.036
Vancouver
Valle-Pastor MJ, Cayuela I, Yebra JS, Senach-Rasilla L, Pastor-Fernández G, Oliva A, et al. Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation. Journal of Allergy and Clinical Immunology. 2026;158(1):164-181. doi:10.1016/j.jaci.2026.02.036
BibTeX
@article{VallePastor2026,
author = {Valle-Pastor, Maria Jesus and Cayuela, Ignacio and Yebra, Jorge S and Senach-Rasilla, Lis and Pastor-Fernández, Gloria and Oliva, Aurea and Traba, Javier and Navarro, Maria N},
title = {Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {158},
number = {1},
pages = {164--181},
doi = {10.1016/j.jaci.2026.02.036}
}
EUVIMED